Main Article Content
Teratology counseling, teratology information services, congenital malformations, cost-effectiveness
While the benefits of evidence - based counseling to large numbers of women and physicians are intuitively evident, there is an urgent need to document that teratology counseling, in addition to improving the quality of life of women and families, also lead s to cost saving. The objective of the present study was to calculate the cost effectiveness of the Motherisk Program, a large teratology information and counseling service at The Hospital for Sick Children and the University of Toronto.
We analyzed data from the Motherisk Program on its 201 2 activities in two domains : 1) Calculation of cost - saving in preventing unjustified pregnancy terminations; and 2) prevention of major birth defects. Cost of pregnancy termination and lifelong cost of specific birth defects were identified from primary literature and prorated for cost of living for the year 2013.
Prevention of 255 pregnancy terminations per year led to cost saving s of $516,630. The total estimated number of major malformations prevented by Motherisk counseling in 2012 was 8.41 cases at a total estimated cost of $9,032,492.
With an estimated minimum annual prevention of 8 major malformations, and numerous unnecessary terminations of otherwise - wanted pregnancies , a cost saving of $10 million can be calculated. In 2013 the operating budget of Motherisk counseling totaled $640,000. Even based on the narrow range of activities for which we calculated cost, this service is highly cost - effective. Because most teratology counseling services are operating in a very similar method to Motherisk, it is fair to assume that these results, although dependent on the size of the service, are generalizable to other countries.
2. In: Medica tion safety in pregnancy and breastfeeding. Koren G, ed. McGraw Hill NY, PP289 - 94 ; 2007 .
3. Koren G, Bologa M, Long D, Feldman Y, Shear NH. Perception of teratogenic risk by pregnant women exposed to d rugs and chemicals during the first trimester. Am J Obstet Gynecol 1989;160:1190 - 4.
4. Koren G, Pastuszak A, Pellegrini E. Prevention of unnecessary pregnancy termination by counseling women on drug, chemical and radiation exposure during the first trimeste r. Teratology 1990;41:657 - 662.
5. Tuns P . The costs and consequences of abortion. The Interim. May 1, 2009 http://www.theinterim.com/issues/abortion/the - cost - and - co nsequences - of - abortion
6. Hoo k B B. Genetic counseling and prenatal cytogenetic ser vices: Policy implications and detailed cost - benefit analysis of programs for the prevention of Down syndrome. In: Poster IH, Hood EB, eds. Services and Education in Medical G enetics. New York: Academic Press, 1979.
7. Schmid W. Economic aspects of prenatal genetic diagnosis. In: Hashem H. ed. Preventable Aspects of Genetic Morbidity, Vol II, Proceedings of the First International Conference of Pr eventable Aspects of Genetic Mo rbidity. Cairo. 1978; pp. 168 - 173 .
8. Perlman D . Birth defects’ cost set at $8 b illion; Government report gives estimates of lifelong bills. San Francisco Chronicle - September 21, 1995 .
9. Economic Costs of Birth Defects and Cerebral Palsy - United State s , 1992. MM WR;1995:44:694 - 9 .
10. Waitzman NJ, Romano PS, Scheffler PM. Estimated of economic costs of birth defects. Inquiry 1994;31:188 - 205 .
11. J . F . L. L ifetime costs of birth defects calculated . Pediatrics 1995;95:141 .
12. Rashbaum W. Complications of abortion. In: Hern WM, Andrikopoulos B, eds: Abortion in the Seventies. New York: National Abortion Federation, 1977, pp33 - 54.
13. Atrash HK, McKay T, Hogue CJ. Ectopic pregnancy con current with induced abortion: Incidence and mortality. Am J Obstet Gynecol 1990;162:725 - 730.
14. Lawso n HW, Atrash HK, Franks AL. Fatal pulmonary embolism during legal induced abortion in the United States from 1972 to 1985. Am J Obstet Gynecol 1990;162:986 - 990.
15. Kaali SG, Szgetvari IA, Bartfai GS. The frequency and management of uterine perforations dur ing first trimester abortions. Am J Obstet Gynecol 1989;161:406 - 408.
16. Pastuszak A, Bhatia D, Okotore B, Koren G. P reconception counseling and women's compliance with folic acid supplementation. Can Fam Physician 1999;45:2053 - 7.
17. Lee A, Moretti ME, Collantes A, Chong D, Mazzotta P, Koren G, et al. Choice of breastfeeding and physicians’ advice: A cohort study of wom en receiving propylthiouracil. Pediatrics 2000;106(1 pt):27 - 30.
18. Walfisch A, Sermer C, Matok I, Einarson A, Koren G. Perception of teratogenic risk and the rated likelihood of pregnancy termination: association with maternal depression. Can J Psychiatry 2011 Dec;56(12):761 - 7.
19. Koren G, Nulman I, Aleksa K, Gareri J, Einarson A, Ito S . Essay for the 2011 CIHR/CMAJ award: Motherisk - caring for mothers, protecting the unborn . Motherisk Progra m. CMAJ 2012;184 :e 155 - 7.
20. Koren G, MacL eod SM. Monitoring and avoiding drug and chemical teratogenicity. Can Med Assoc J 1986;135:1079 - 1081.